Adia Med Inc. (ADIA)
Adia Med Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Winter Park, FL, US. The stock last traded at $0.11, down 1.79% on the session, giving a market capitalisation of $10.4M. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of -56.5%. Its beta of -8.23 implies it has historically moved less than the broad market.
Adia Med Inc. is a publicly traded company dedicated to advancing regenerative medicine and healthcare innovation. The company operates through its primary divisions: Adia Med clinics and Adia Labs LLC. Adia Med clinics deliver specialized regenerative treatments, including stem cell therapies, while Adia Labs manufactures and distributes regenerative products. The company is also involved in multiple Institutional Review Board (IRB)-approved clinical studies.
Adia Med Inc. is most often compared with the following Healthcare names: